Revised criteria for the diagnosis and staging of Alzheimer's disease.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 38942991.
- Also identified by DOI 10.1038/s41591-024-02988-7 and PMC identifier 11630478.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alzheimer’s disease can be treated by targeting amyloid-β plaques and diagnosed in vivo by biomarkers, prompting the revision of criteria for the diagnosis and staging of this disease.
Medical subject headings
- Alzheimer Disease